Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Formula Systems (1985) Ltd is an information technology services business based in the US. Formula Systems 1985 shares (FORTY) are listed on the NASDAQ and all prices are listed in US Dollars. Formula Systems 1985 employs 15,101 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$107.29|
|52-week range||$74.18 - $112.35|
|50-day moving average||$99.43|
|200-day moving average||$91.79|
|Wall St. target price||N/A|
|Dividend yield||$1.44 (1.36%)|
|Earnings per share (TTM)||$3.23|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-15)||-0.01%|
|1 month (2021-09-23)||3.51%|
|3 months (2021-07-23)||23.89%|
|6 months (2021-04-23)||15.93%|
|1 year (2020-10-19)||25.93%|
|2 years (2019-10-19)||N/A|
|3 years (2018-10-23)||187.05%|
|5 years (2016-10-19)||N/A|
Valuing Formula Systems 1985 stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Formula Systems 1985's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Formula Systems 1985's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 33x. In other words, Formula Systems 1985 shares trade at around 33x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Formula Systems 1985's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $254.1 million.
The EBITDA is a measure of a Formula Systems 1985's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$2.2 billion|
|Operating margin TTM||8.63%|
|Gross profit TTM||$447.4 million|
|Return on assets TTM||4.97%|
|Return on equity TTM||12.56%|
|Market capitalisation||$1.6 billion|
TTM: trailing 12 months
There are currently 5,231 Formula Systems 1985 shares held short by investors – that's known as Formula Systems 1985's "short interest". This figure is 6.6% up from 4,905 last month.
There are a few different ways that this level of interest in shorting Formula Systems 1985 shares can be evaluated.
Formula Systems 1985's "short interest ratio" (SIR) is the quantity of Formula Systems 1985 shares currently shorted divided by the average quantity of Formula Systems 1985 shares traded daily (recently around 5564.8936170213). Formula Systems 1985's SIR currently stands at 0.94. In other words for every 100,000 Formula Systems 1985 shares traded daily on the market, roughly 940 shares are currently held short.
However Formula Systems 1985's short interest can also be evaluated against the total number of Formula Systems 1985 shares, or, against the total number of tradable Formula Systems 1985 shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Formula Systems 1985's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Formula Systems 1985 shares in existence, roughly 0 shares are currently held short) or 0.0005% of the tradable shares (for every 100,000 tradable Formula Systems 1985 shares, roughly 1 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Formula Systems 1985.
Find out more about how you can short Formula Systems 1985 stock.
Dividend payout ratio: 44.37% of net profits
Recently Formula Systems 1985 has paid out, on average, around 44.37% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.34% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Formula Systems 1985 shareholders could enjoy a 1.34% return on their shares, in the form of dividend payments. In Formula Systems 1985's case, that would currently equate to about $1.44 per share.
While Formula Systems 1985's payout ratio might seem fairly standard, it's worth remembering that Formula Systems 1985 may be investing much of the rest of its net profits in future growth.
Formula Systems 1985's most recent dividend payout was on 3 October 2021. The latest dividend was paid out to all shareholders who bought their shares by 30 August 2021 (the "ex-dividend date").
Over the last 12 months, Formula Systems 1985's shares have ranged in value from as little as $74.1791 up to $112.35. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Formula Systems 1985's is 0.424. This would suggest that Formula Systems 1985's shares are less volatile than average (for this exchange).
Formula Systems (1985) Ltd. , through its subsidiaries, provides software, proprietary and non-proprietary software, and software product marketing and support services in Israel and internationally. The company offers computer and telecommunication infrastructure solutions; computer solutions to computer and communications infrastructures; cloud computing solutions; database and big data services; customer relations management, computer systems management infrastructures, web world content management, database and data warehouse mining, application integration, database and systems, data management, and software development tools; and professional training courses and advanced professional studies. It also markets and sells computers and peripheral equipment to business customers. In addition, the company offers property and casualty insurance platforms, such as Sapiens, Sapiens CoreSuite, Sapiens IDITSuite, Sapiens PolicyPro, Sapiens BillingPro, Sapiens ClaimsPro, e-Tica, and Tia Enterprise; life, pension, and annuities platforms, including Sapiens CoreSuite, Sapiens UnderwritingPro, Sapiens ApplicationPro, Sapiens IllustrationPro, and Sapiens ConsolidationMaster; reinsurance software solutions comprising Sapiens ReinsuranceMaster, Sapiens ReinsurancePro, and Sapiens Reinsurance GO; and Sapiens platform for workers' compensation solutions. Further, it provides financial and compliance solutions that include Sapiens FinancialPro, Sapiens Financial GO, and Sapiens StatementPro; Sapiens DECISION, a decision management platform; and technology-based solutions and digital insurance suites. Additionally, the company offers application development and business process integration platforms; vertical software solutions; software services and information technologies outsourcing software services; and professionals in various areas, as well as develops on-premise payroll software solutions.
Steps to owning and managing Valkyrie Bitcoin Strategy ETF units.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.